ACUTAAS CHEMICALS LTD
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications. It als… Read more
Market Cap & Net Worth: ACUTAAS CHEMICALS LTD (ACUTAAS)
ACUTAAS CHEMICALS LTD (NSE:ACUTAAS) has a market capitalization of $231.16K (₹20.02 Million) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #39146 globally and #2062 in its home market, demonstrating a -3.81% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ACUTAAS CHEMICALS LTD's stock price ₹2165.00 by its total outstanding shares 9247 (9.25K).
ACUTAAS CHEMICALS LTD Market Cap History: 2025 to 2026
ACUTAAS CHEMICALS LTD's market capitalization history from 2025 to 2026. Data shows growth from $182.04K to $231.16K (0.00% CAGR).
ACUTAAS CHEMICALS LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ACUTAAS CHEMICALS LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
ACUTAAS CHEMICALS LTD's market cap is 0.00 times its annual revenue
0.52x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
ACUTAAS CHEMICALS LTD's market cap is 0.00 times its annual earnings
593.18x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $182.04K | $10.07 Billion | $1.59 Billion | 0.00x | 0.00x |
Competitor Companies of ACUTAAS by Market Capitalization
Companies near ACUTAAS CHEMICALS LTD in the global market cap rankings as of March 18, 2026.
Key companies related to ACUTAAS CHEMICALS LTD by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #72 globally with a market cap of $210.18 Billion USD.
- L'Air Liquide S.A (PINK:AIQUF): Ranked #182 globally with a market cap of $107.70 Billion USD.
- Air Liquide SA (PA:AI): Ranked #200 globally with a market cap of $99.38 Billion USD ( €96.82 Billion EUR).
- Ecolab Inc (NYSE:ECL): Ranked #266 globally with a market cap of $77.95 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #72 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $497.41 |
| #182 | L'Air Liquide S.A | PINK:AIQUF | $107.70 Billion | $187.03 |
| #200 | Air Liquide SA | PA:AI | $99.38 Billion | €172.20 |
| #266 | Ecolab Inc | NYSE:ECL | $77.95 Billion | $273.11 |
ACUTAAS CHEMICALS LTD Historical Marketcap From 2025 to 2026
Between 2025 and today, ACUTAAS CHEMICALS LTD's market cap moved from $182.04K to $ 231.16K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹231.16K | +26.99% |
| 2025 | ₹182.04K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of ACUTAAS CHEMICALS LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $231.16K USD |
| MoneyControl | $231.16K USD |
| MarketWatch | $231.16K USD |
| marketcap.company | $231.16K USD |
| Reuters | $231.16K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.